Martin van den Bent, MD, Erasmus MC Cancer Center, discusses the results from the ABT-414 trial for patients with brain cancer.
Martin van den Bent, MD, PhD
Advertisement
Articles by Martin van den Bent, MD, PhD
Advertisement
Latest Updated Articles
Results for ABT-414 in Brain CancerNovember 17th 2016
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Insurance Delays and Travel Strain CAR T Referral in Early Relapsed Myeloma
2
NCCN Guidelines Add Cosibelimab for Locally Advanced CSCC
3
Real-World Data for Darolutamide vs Abiraterone Triplet Therapy in mHSPC
4
Sofetabart Mipitecan Elicits Responses Across FRα Levels in Ovarian Cancer
5